| kbrouwer@unc.edu
Division Chair
George H. Cocolas Distinguished Professor Research Interest Mechanisms of hepatic uptake, translocation and biliary excretion; drug transport; aberrant gastrointestinal drug absorption phenomena; pharmacokinetics. |
| ahcorbet@email.unc.edu
Clinical Assistant Professor Research Interest Pharmacology of antiretrovirals and opportunistic infection therapies in resource poor countries. | 
| re_dupuis@unc.edu
Clinical Associate Professor Research Interest Clinical pharmacokinetics/ drug metabolism of immunosuppressants in organ transplant recipients; drug interactions with these agents and the relationship between drug metabolism (phenotype and genotype), toxicity and outcomes. | 
| rhawke@email.unc.edu
Assistant Professor Research Interests The role of drug metabolism enzymes (cytochrome P450s) and hepatobiliary transporters in liver disease pathobiology and drug-induced hepatotoxicity; clinical investigations in patients with hepatitis C or NASH (nonalcoholic steatohepatitis), with focus on the association of disease progression and treatment response with: 1) serum biomarkers of inflammation, apoptosis, fibrosis/cirrhosis; and 2) genetic polymorphisms or activity phenotypes for candidate cytochrome P450 and hepatobiliary transporter genes. | 
| akashuba@unc.edu
Associate Professor Research Interests Clinical pharmacology of antiretroviral agents used in the treatment of HIV infection, specifically the role of antiretroviral therapy in preventing the transmission of HIV, determining optimal dosing and drug combinations for the treatment of HIV infection, understanding and predicting drug-drug and drug-cytokine interactions and adverse effects, and role of sex and ethnicity in drug disposition. | 
| craig_lee@unc.edu
Assistant Professor Research Interests The role of genomics in the development, progression and treatment of cardiovascular disease, with a focus on eicosanoid metabolism and endothelial dysfunction. | 
| hmcleod@unc.edu
Fred Eshelman Distinguished Professor
Director, Institute for Pharmacogenomics and Individualized Therapy |
| mpaine@med.unc.edu
Research Assistant Professor Research Interests Clinical pharmacokinetics, drug metabolism and transport, and pharmacogenetics; currently investigating pharmacokinetic mechanisms underlying drug-drug and drug-diet interactions. | 
| hpatterson@unc.edu
Professor
Research Professor of Medicine Research Interests Clinical research of drugs used in heart failure. | 
| apersky@unc.edu
Clinical Associate Professor Research Interests Pharmacy education; pharmacokinetics and pharmacodynamics of dietary supplements; interaction of exercise and/or nutrition on drug disposition and action; skeletal muscle physiology and pathophysiology and agents that influence form and function. | 
| gary_pollack@unc.edu
Executive Associate Dean
Professor Research Interests Kinetics of blood-brain barrier transport, neuronal receptor binding, and central nervous system effects of xenobiotics; approaches to selective CNS delivery of therapeutic agents; kinetics and mechanisms of opioid tolerance development; contribution of metabolites to the pharmacologic/toxicologic effects of xenobiotics; data analysis methods for pharmacokinetic/pharmacodynamic systems; innovative instructional approaches for pharmacokinetics and pharmacodynamics. | 
| jerodgers@unc.edu
Clinical Assistant Professor Research Interests Clinical and translational research in heart failure. | 
| christine_walko@unc.edu
Assistant Professor Research Interests Oncology-based research in translational pharmacology, Phase I/II trials, pharmacokinetics, and pharmacogenomics. | 
| michael.wang@unc.edu
Research Assistant Professor Research Interests Drug metabolism and pharmacokinetics; transport of organic cations; quantitative proteomic applications in translational pharmaceutical sciences; CYP4F-mediated metabolism of xenobiotics and endogenous compounds. | 
| pbwatkins@med.unc.edu
Director, General Clinical Research Center Research Interests Dr. Watkins is interested in mechanisms that underlie serious liver injury due to drugs. His research spans preclinical models to patients in clinical trials and utilizes current genomics technologies,including genetics, transcriptomics and metabolomics. |
|
Faculty Spotlight
Read more about
Howard McLeod, a
Fred Eshelman
Distinguished
Professor |
Fifth Annual Organ Systems Pharmacology Short Course
McLeod featured in University marketing campaign
